July 23, 2026 · Form 4 insider transaction
Levy Adam R. bought 160,000 shares of NEXGEL, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
The option becomes exercisable as to 40,000 shares on December 31, 2026, and as to the remaining 120,000 shares in 36 equal monthly installments of 3,334 shares (with rounding adjustments) beginning January 31, 2027, in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. In the event of a Change in Control (as defined in the Reporting Person's Executive Employment Agreement with the Issuer, dated July 23, 2026), any unvested portion of the option will accelerate and become immediately exercisable in full.